Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Labenz

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Expert Opinion on Pharmacotherapy|December 24, 2005
An update on the available treatments for non-erosive reflux diseaseJoachim Labenz, Andrea Morgner-Miehlke
Deutsche Medizinische Wochenschrift (1946)|May 14, 2015
[Chronic abdominal pain: these diseases can be the cause]Joachim Labenz, Christian Labenz, Manfred Gross
World Journal of Gastroenterology|January 21, 2006
Management of functional dyspepsia: Unsolved problems and new perspectivesAhmed Madisch, Stephan Miehlke, Joachim Labenz
Expert Opinion on Pharmacotherapy|May 3, 2007
Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcersAndrea Morgner, Stephan Miehlke, Joachim Labenz
MMW Fortschritte Der Medizin|March 22, 2019
[Functional dyspepsia in primary care: therapeutic variety or helplessness?]Christian Labenz, Ahmed Madisch, Joachim Labenz
Expert Opinion on Investigational Drugs|August 19, 2006
Effective regimens for the treatment of Helicobacter pylori infectionAndrea Morgner, Joachim Labenz, Stephan Miehlke
Hepatology (Baltimore, Md.)|December 27, 2021
Letter to the editor: Evidence on the use of l-ornithine l-aspartate in overt HE-But does it really improve prognosis?Christian Labenz, Joachim Labenz, Peter R Galle
F1000Research|July 11, 2022
Burnout and work satisfaction are differentially associated in gastroenterologists in GermanyCharles Christian Adarkwah, Joachim Labenz, Oliver Hirsch
Digestive Diseases (Basel, Switzerland)|May 16, 2006
NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary careMargrit Hollenz, Manfred Stolte, Andreas Leodolter, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 8, 2010
[Modern Helicobacter pylori therapies in times of increasing anti biotic resistance]Marco Berning, Susanne Krasz, Joachim Labenz, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Expert Opinion on Pharmacotherapy|December 24, 2005
An update on the available treatments for non-erosive reflux diseaseJoachim Labenz, Andrea Morgner-Miehlke
Deutsche Medizinische Wochenschrift (1946)|May 14, 2015
[Chronic abdominal pain: these diseases can be the cause]Joachim Labenz, Christian Labenz, Manfred Gross
World Journal of Gastroenterology|January 21, 2006
Management of functional dyspepsia: Unsolved problems and new perspectivesAhmed Madisch, Stephan Miehlke, Joachim Labenz
Expert Opinion on Pharmacotherapy|May 3, 2007
Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcersAndrea Morgner, Stephan Miehlke, Joachim Labenz
MMW Fortschritte Der Medizin|March 22, 2019
[Functional dyspepsia in primary care: therapeutic variety or helplessness?]Christian Labenz, Ahmed Madisch, Joachim Labenz
Expert Opinion on Investigational Drugs|August 19, 2006
Effective regimens for the treatment of Helicobacter pylori infectionAndrea Morgner, Joachim Labenz, Stephan Miehlke
Hepatology (Baltimore, Md.)|December 27, 2021
Letter to the editor: Evidence on the use of l-ornithine l-aspartate in overt HE-But does it really improve prognosis?Christian Labenz, Joachim Labenz, Peter R Galle
F1000Research|July 11, 2022
Burnout and work satisfaction are differentially associated in gastroenterologists in GermanyCharles Christian Adarkwah, Joachim Labenz, Oliver Hirsch
Digestive Diseases (Basel, Switzerland)|May 16, 2006
NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary careMargrit Hollenz, Manfred Stolte, Andreas Leodolter, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 8, 2010
[Modern Helicobacter pylori therapies in times of increasing anti biotic resistance]Marco Berning, Susanne Krasz, Joachim Labenz, et al.
Pageof 10